Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells-Reference-Cited by-同舟云学术

Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells

Published:2018-08-16 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Maria-Ferreira Daniele^ORCID,Nascimento Adamara Machado,Cipriani Thales Ricardo,Santana-Filho Arquimedes Paixão,Watanabe Paulo da Silva^ORCID,Sant´Ana Debora de Mello Gonçales,Luciano Fernando Bittencourt,Bocate Karla Carolina Paiva,van den Wijngaard René M.,Werner Maria Fernanda de Paula,Baggio Cristiane Hatsuko^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-30526-2.pdf

Reference44 articles.

1. Hartog, A. et al. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides. J. Nutr. Biochem. 26, 227–233 (2015).

2. Burisch, J. & Munkholm, P. The epidemiology of inflammatory bowel disease. Scand. J. Gastroenterol. 50, 942–951 (2015).

3. De Souza, H. S. P. & Fiocchi, C. Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13, 13–27 (2016).

4. Dignass, A. et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: current management. J. Crohns Colitis 6, 991–1030 (2012).

5. Debnath, T., Kim, D. H. & Lim, B. O. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules 18, 7253–7270 (2013).

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Grifola frondosa polysaccharide's therapeutic potential in oxazolone-induced ulcerative colitis;Carbohydrate Polymers;2024-11

2. Water-soluble garlic polysaccharide (WSGP) improves ulcerative volitis by modulating the intestinal barrier and intestinal flora metabolites;Scientific Reports;2024-09-14

3. Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review;Archives of Toxicology;2024-09-09

4. Harnessing nature’s pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis;Frontiers in Pharmacology;2024-08-14

5. SARS-CoV-2 Spike protein triggers gut impairment since mucosal barrier to innermost layers: From basic science to clinical relevance;Mucosal Immunology;2024-08